Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 341

Similar articles for PubMed (Select 15498563)

1.

The SEP domain of p47 acts as a reversible competitive inhibitor of cathepsin L.

Soukenik M, Diehl A, Leidert M, Sievert V, Büssow K, Leitner D, Labudde D, Ball LJ, Lechner A, Nägler DK, Oschkinat H.

FEBS Lett. 2004 Oct 22;576(3):358-62.

2.

Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides.

Guay J, Falgueyret JP, Ducret A, Percival MD, Mancini JA.

Eur J Biochem. 2000 Oct;267(20):6311-8.

3.

Human cathepsin X. A novel cysteine protease with unique specificity.

Ménard R, Nägler DK, Zhang R, Tam W, Sulea T, Purisima EO.

Adv Exp Med Biol. 2000;477:317-22. No abstract available.

PMID:
10849759
4.

Selective inhibition of the collagenolytic activity of human cathepsin K by altering its S2 subsite specificity.

Lecaille F, Choe Y, Brandt W, Li Z, Craik CS, Brömme D.

Biochemistry. 2002 Jul 2;41(26):8447-54.

PMID:
12081494
5.

Inhibition of a cathepsin L-like cysteine protease by a chimeric propeptide-derived inhibitor.

Godat E, Chowdhury S, Lecaille F, Belghazi M, Purisima EO, Lalmanach G.

Biochemistry. 2005 Aug 9;44(31):10486-93.

PMID:
16060657
6.

The slow-binding inhibition of cathepsin K by its propeptide.

Billington CJ, Mason P, Magny MC, Mort JS.

Biochem Biophys Res Commun. 2000 Oct 5;276(3):924-9.

PMID:
11027570
7.

Saxiphilin, a saxitoxin-binding protein with two thyroglobulin type 1 domains, is an inhibitor of papain-like cysteine proteinases.

Lenarcic B, Krishnan G, Borukhovich R, Ruck B, Turk V, Moczydlowski E.

J Biol Chem. 2000 May 19;275(20):15572-7.

8.

Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L.

Bocock JP, Edgell CJ, Marr HS, Erickson AH.

Eur J Biochem. 2003 Oct;270(19):4008-15.

9.
10.

Identification and characterization of a cathepsin L-like cysteine protease from Gnathostoma spinigerum.

Kongkerd N, Uparanukraw P, Morakote N, Sajid M, McKerrow JH.

Mol Biochem Parasitol. 2008 Aug;160(2):129-37. doi: 10.1016/j.molbiopara.2008.05.001. Epub 2008 May 8.

PMID:
18554733
11.

Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity.

Brömme D, Bonneau PR, Lachance P, Storer AC.

J Biol Chem. 1994 Dec 2;269(48):30238-42.

12.
13.

Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain.

Lenarcic B, Ritonja A, Strukelj B, Turk B, Turk V.

J Biol Chem. 1997 May 23;272(21):13899-903.

14.

Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.

Falgueyret JP, Oballa RM, Okamoto O, Wesolowski G, Aubin Y, Rydzewski RM, Prasit P, Riendeau D, Rodan SB, Percival MD.

J Med Chem. 2001 Jan 4;44(1):94-104.

PMID:
11141092
15.
16.

Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.

Lalmanach G, Serveau C, Brillard-Bourdet M, Chagas JR, Mayer R, Juliano L, Gauthier F.

J Protein Chem. 1995 Nov;14(8):645-53.

PMID:
8747425
17.

Partial characterization of a novel cathepsin L-like protease from Fasciola hepatica.

Hawthorne SJ, Pagano M, Halton DW, Walker B.

Biochem Biophys Res Commun. 2000 Oct 14;277(1):79-82.

PMID:
11027643
18.

The amino acid sequences, structure comparisons and inhibition kinetics of sheep cathepsin L and sheep stefin B.

Ritonja A, Coetzer TH, Pike RN, Dennison C.

Comp Biochem Physiol B Biochem Mol Biol. 1996 Jun;114(2):193-8.

PMID:
8759291
20.

Recombinant cathepsin S propeptide attenuates cell invasion by inhibition of cathepsin L-like proteases in tumor microenvironment.

Burden RE, Snoddy P, Buick RJ, Johnston JA, Walker B, Scott CJ.

Mol Cancer Ther. 2008 Mar;7(3):538-47. doi: 10.1158/1535-7163.MCT-07-0528.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk